Medical News

RSS

Phase II study results of riociguat for CTEPH and PAH published online

Bayer HealthCare Pharmaceuticals, Inc. today announced that the study "Riociguat for chronic thromboembolic pulmonary hypertension and pulmonary arterial hypertension: a phase II study" was published online this week by the European Respiratory Journal. Results of this study to assess the safety, tolerability and the feasibility of individual dose titration of riociguat were previously presented at the 2009 International Conference of the American Thoracic Society.

11 Jun 2010

Castlight Health raises $60M in Series C funding

Castlight Health, the first company to empower consumers with information to effectively navigate the health care system, today announced that it has raised $60 million in Series C funding. The round included new investors Morgan Stanley Investment Management, The Wellcome Trust, U.S. Venture Partners, and Cleveland Clinic, as well as existing investors Maverick Capital, Oak Investment Partners and Venrock.

11 Jun 2010

Senate continues consideration of 'tax extenders,' Democrats push for COBRA subsidy

CongressDaily: The Senate is continuing work on a $140 billion package of tax breaks that includes some unemployment benefits and a temporary fix of the payments to Medicare physicians. "Final passage is not expected until next week on what is likely to be a partisan vote. But there are areas of agreement across the aisle.

11 Jun 2010

Ambulatory Surgery Center industry responds to infection control concerns raised in JAMA

As leading organizations representing the Ambulatory Surgery Center (ASC) industry, we wish to address concerns raised in this month's issue of the Journal of the American Medical Association (JAMA) highlighting data from a 2008 Centers for Medicare and Medicaid Services (CMS) pilot study. The industry underscores its strong commitment to patient safety and its nationwide efforts to provide high-quality, patient-centered care at a low cost to the health care system.

11 Jun 2010

Thousands of Minnesota nurses strike for one day

More than 12,000 nurses launched a one-day strike Thursday at 14 Minnesota hospitals in a dispute over nurse-patient ratios levels and pension benefits. Nurses say they are being asked to care for too many patients at a time, and strict ratios are necessary to protect patient safety. The hospitals, all in the Minneapolis area, counter that patients are safe and that the walkout is a headline-grabbing stunt to build membership and clout for a national nurses union.

11 Jun 2010

PRA International to host interactive round-table sessions on drug development, lifecycle management

PRA International, a leading Clinical Research Organization, will host five interactive round-table sessions on drug development and lifecycle management at the Drug Information Association's annual meeting in Washington, D.C. 13-17 June 2010.

11 Jun 2010

Gulf cleanup volunteers are putting themselves at risk of long-term health effects

With more oil from the BP spill in the Gulf washing ashore, regional communities will have a huge job of cleaning up after this vast environmental disaster. As kind-hearted volunteers participate in the effort to save both wildlife and the local environment, they will be putting themselves at risk of long-term health effects.

11 Jun 2010

Boston Scientific announces event schedule at 17th Cardiostim World Congress

Boston Scientific Corporation today announced the schedule of the Company's key events and sponsored research at the 17th Cardiostim World Congress, June 16 – 19 in Nice, France.

11 Jun 2010

Phase 2b RESTORE-CLI clinical trial in patients with CLI reaches statistical significance

Richard J. Powell, M.D., section chief of vascular surgery at the Dartmouth-Hitchcock Medical Center in Lebanon, NH and a principal investigator of the U.S. Phase 2b RESTORE-CLI clinical trial sponsored by Aastrom Biosciences, will present the full results from the interim analysis at today's session of the annual meeting of the Society for Vascular Surgery.

11 Jun 2010

Researchers demonstrate efficacy of routine psychotherapeutic treatment for depression

Depression is one of the most common forms of psychiatric disorder. It can occur at any time of life and it may affect children and adolescents as well as the elderly. However, depression can usually be suitably managed with the help of cognitive behavioral therapy. Researchers based at Johannes Gutenberg University Mainz have been able to demonstrate both the efficacy and the extent of the beneficial effect of routine psychotherapeutic treatment for depression.

11 Jun 2010

Waismann Method survey: 88% of individuals taken prescription painkillers for chronic pain relief

According to a recent survey conducted by the Waismann Method of opiate detoxification, doctors prescribing medication for the treatment of chronic pain were found to be the leading source of prescription painkiller use. Approximately 88 percent of all respondents stated they began taking prescription painkillers for chronic pain relief, with an astounding 70 percent of these individuals believing that they experience the same or a greater amount of pain than when originally prescribed painkillers.

11 Jun 2010

Excess Re introduces unlimited annual maximums on stop-loss policies

Excess Reinsurance Underwriters Agency, Inc. (Excess Re), a stop-loss managing general underwriter and wholly-owned subsidiary of National Financial Partners Corp., a provider of benefits, insurance and investment services, announced today that it is introducing unlimited annual maximums on its stop-loss policies.

11 Jun 2010

PharmaTrust to demonstrate MedCenter technology at Annual Healthcare Conference

PharmaTrust has been invited to participate in the Private Company forum of the Goldman Sachs 31st Annual Healthcare Conference in Los Angeles, June 14th to 17th. The company will demonstrate its revolutionary Healthcare…Everywhere MedCenter which will connect conference 'patients' in Los Angeles to PharmaTrust pharmacists in Toronto.

11 Jun 2010

TransEnterix selects SYSPRO ERP software

SYSPRO, the leading provider of visionary, pragmatic ERP software, has today announced that TransEnterix, a fast-growing medical device manufacturer based in Durham, North Carolina, has selected SYSPRO ERP software after a lengthy selection process that included a thorough analysis of seven mid-range ERP software providers.

11 Jun 2010

Sundise to implement Medidata Rave as its EDC and CDM solution

Medidata Solutions, a leading global provider of SaaS-based clinical development solutions, today announced that Traditional Chinese Medicine company Sundise will implement Medidata Rave as its electronic data capture and clinical data management solution. Selected for its ability to offer a broad global reach with local in-country support, Medidata will work with Sundise to conduct its first U.S. trial for its TCM treatment for liver fibrosis and will play a key role in supporting the company's strategy to launch in the U.S.

11 Jun 2010

Takeda receives pricing approval for NESINA in Japan

Furiex Pharmaceuticals, Inc. today confirmed that Takeda Pharmaceutical Company Limited has received pricing approval for NESINA® (alogliptin) in Japan. NESINA, a highly selective DPP-4 inhibitor for the treatment of type 2 diabetes, received regulatory approval from the Japanese Ministry of Health, Labour and Welfare on April 16, 2010. Furiex collaborated with Takeda to develop this product.

11 Jun 2010

Trevena's scientists present research data on GPCR biased ligands at two scientific conferences

Trevena Inc., a leader in the discovery of G-protein coupled receptor biased ligands, today announced that its scientists are presenting research data at two scientific conferences. These oral presentations highlight Trevena's research demonstrating that ligand bias at the angiotensin II type I receptor translates into differentiable and beneficial cardiovascular pharmacology in vivo.

11 Jun 2010

NeoPharm first-quarter net loss decreases to $1.4 million

NeoPharm, Inc., a publicly traded biopharmaceutical company dedicated to the research, development and commercialization of new and innovative therapeutic applications of drugs for cancer and other diseases, today announced its first quarter 2010 financial results.

11 Jun 2010

Cook Medical files for PMA of Zilver PTX Drug-Eluting Peripheral Stent with FDA

Cook Medical has submitted its Pre-Market Approval (PMA) application to the U.S. Food and Drug Administration (FDA) for the company's unique polymer-free Zilver® PTX® Drug-Eluting Peripheral Stent. Intended for use in patients with peripheral arterial disease (PAD) in the superficial femoral artery (SFA), Zilver PTX is a self-expanding, highly durable nitinol stent that uses a proprietary, polymer-free technology to deliver a locally therapeutic dose of paclitaxel, an antiproliferative drug, to the target lesion.

11 Jun 2010

Overview of research into pathogenesis and clinical treatment of dry eye

Dry eye is one of the most common disorders encountered in ophthalmological practice. Its symptoms cause considerable discomfort and substantially reduce the patient's quality of life. As it is a complex and multifactorial condition, research investigating dry eye is a matter of great interest all over the world.

11 Jun 2010

Medical News

Phase II study results of riociguat for CTEPH and PAH published online

Castlight Health raises $60M in Series C funding

Senate continues consideration of 'tax extenders,' Democrats push for COBRA subsidy

Ambulatory Surgery Center industry responds to infection control concerns raised in JAMA

Thousands of Minnesota nurses strike for one day

PRA International to host interactive round-table sessions on drug development, lifecycle management

Gulf cleanup volunteers are putting themselves at risk of long-term health effects

Boston Scientific announces event schedule at 17th Cardiostim World Congress

Phase 2b RESTORE-CLI clinical trial in patients with CLI reaches statistical significance

Researchers demonstrate efficacy of routine psychotherapeutic treatment for depression

Waismann Method survey: 88% of individuals taken prescription painkillers for chronic pain relief

Excess Re introduces unlimited annual maximums on stop-loss policies

PharmaTrust to demonstrate MedCenter technology at Annual Healthcare Conference

TransEnterix selects SYSPRO ERP software

Sundise to implement Medidata Rave as its EDC and CDM solution

Takeda receives pricing approval for NESINA in Japan

Trevena's scientists present research data on GPCR biased ligands at two scientific conferences

NeoPharm first-quarter net loss decreases to $1.4 million

Cook Medical files for PMA of Zilver PTX Drug-Eluting Peripheral Stent with FDA

Overview of research into pathogenesis and clinical treatment of dry eye

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News